Exenatide (Byetta) was the first GLP-1R agonist to be prescribed for the treatment of T2DM and is a synthetic analog of the GLP-1R agonist, Ex-4
8 Moreover, changes in systemic energy metabolism may impair the energetic support necessary for skeletal homeostasis and influence bone-active hormonal pathways
Employers took a range of approaches, with some using specialized vendors to provide case management and in other cases, organizing the requirement through the health plan
What to inject: 3.0 mL reconstitution: 7.5 units once weekly 2.0 mL reconstitution: 5 units once weekly 4.0 mL reconstitution: 10 units once weekly What to expect: Mild appetite suppression is common by week 2
Both compounds were presented once in 24 hours and examined on days 1, 2, 4, 7, and 14
Valvassori SS, Mariot E, Varela RB, Bavaresco DV, Dal-Pont GC, Ferreira CL, et al